17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Schizophrenia Disease or Phenotype (Entity type)
17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Mu-type opioid receptor Protein (Entity type)	Ki
17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Kappa-type opioid receptor Protein (Entity type)	Ki
17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Delta-type opioid receptor Protein (Entity type)	Ki
17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Bipolar I disorder Disease or Phenotype (Entity type)

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Schizophrenia
Disease or Phenotype (Entity type)

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Mu-type opioid receptor
Protein (Entity type)
Ki

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Kappa-type opioid receptor
Protein (Entity type)
Ki

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Delta-type opioid receptor
Protein (Entity type)
Ki

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Bipolar I disorder
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide (Compound)

Analyze

Knowledge Graph Assertions

Consortium

Community

Resources

Consortium

Community

Resources